Estradiol transdermal - Bayer HealthCare Pharmaceuticals
Alternative Names: Climara; Estradiol transdermal - Berlex/3M; Femtran; Progynova TS 100; Progynova TS 50; Progynova TS ForteLatest Information Update: 09 Jan 2025
At a glance
- Originator 3M Pharmaceuticals; Bayer HealthCare Pharmaceuticals
- Developer 3M Pharmaceuticals; AbbVie; Bayer HealthCare Pharmaceuticals Inc.
- Class Antineoplastics; Estradiol congeners; Estrenes; Hormonal replacements; Small molecules
- Mechanism of Action Estrogen receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Menopausal syndrome; Postmenopausal osteoporosis
Most Recent Events
- 04 Dec 2024 ADVANZ PHARMA purchases Estradiol transdermal in selected countries in APAC countries (excluding Japan and China) from Bayer
- 18 Oct 2023 ADVANZ PHARMA purchases Estradiol transdermal in selected countries in Latin America from Bayer
- 08 May 2020 Allergan has been acquired and merged into AbbVie